These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 20637863)

  • 1. Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models.
    Mars LT; Saikali P; Liblau RS; Arbour N
    Biochim Biophys Acta; 2011 Feb; 1812(2):151-61. PubMed ID: 20637863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collateral bystander damage by myelin-directed CD8+ T cells causes axonal loss.
    Sobottka B; Harrer MD; Ziegler U; Fischer K; Wiendl H; Hünig T; Becher B; Goebels N
    Am J Pathol; 2009 Sep; 175(3):1160-6. PubMed ID: 19700745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-recognition of a myelin peptide by CD8+ T cells in the CNS is not sufficient to promote neuronal damage.
    Reuter E; Gollan R; Grohmann N; Paterka M; Salmon H; Birkenstock J; Richers S; Leuenberger T; Brandt AU; Kuhlmann T; Zipp F; Siffrin V
    J Neurosci; 2015 Mar; 35(12):4837-50. PubMed ID: 25810515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of T cell Ig mucin-3 signaling on central nervous system autoimmune disease is determined by the effector function of the pathogenic T cells.
    Lee SY; Goverman JM
    J Immunol; 2013 May; 190(10):4991-9. PubMed ID: 23562810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutting edge: Multiple sclerosis-like lesions induced by effector CD8 T cells recognizing a sequestered antigen on oligodendrocytes.
    Saxena A; Bauer J; Scheikl T; Zappulla J; Audebert M; Desbois S; Waisman A; Lassmann H; Liblau RS; Mars LT
    J Immunol; 2008 Aug; 181(3):1617-21. PubMed ID: 18641296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MHC class I-restricted myelin epitopes are cross-presented by Tip-DCs that promote determinant spreading to CD8⁺ T cells.
    Ji Q; Castelli L; Goverman JM
    Nat Immunol; 2013 Mar; 14(3):254-61. PubMed ID: 23291597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelin-specific CD8+ T cells exacerbate brain inflammation in CNS autoimmunity.
    Wagner CA; Roqué PJ; Mileur TR; Liggitt D; Goverman JM
    J Clin Invest; 2020 Jan; 130(1):203-213. PubMed ID: 31573979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the roles of CD8(+) T lymphocytes in the pathogenesis of autoimmune demyelination.
    Johnson TA; Jirik FR; Fournier S
    Semin Immunopathol; 2010 Jun; 32(2):197-209. PubMed ID: 20237782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroantigen-specific autoregulatory CD8+ T cells inhibit autoimmune demyelination through modulation of dendritic cell function.
    Kashi VP; Ortega SB; Karandikar NJ
    PLoS One; 2014; 9(8):e105763. PubMed ID: 25144738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental autoimmune encephalomyelitis mediated by CD8+ T cells.
    Ji Q; Goverman J
    Ann N Y Acad Sci; 2007 Apr; 1103():157-66. PubMed ID: 17376824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple Sclerosis and T Lymphocytes: An Entangled Story.
    Legroux L; Arbour N
    J Neuroimmune Pharmacol; 2015 Dec; 10(4):528-46. PubMed ID: 25946987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Autoregulatory CD8 T Cells Require IFN-γ Responsiveness to Optimally Suppress Central Nervous System Autoimmunity.
    Boyden AW; Brate AA; Stephens LM; Karandikar NJ
    J Immunol; 2020 Jul; 205(2):359-368. PubMed ID: 32532836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into the immunopathogenesis of multiple sclerosis.
    Hellings N; Raus J; Stinissen P
    Immunol Res; 2002; 25(1):27-51. PubMed ID: 11868933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?
    Friese MA; Fugger L
    Brain; 2005 Aug; 128(Pt 8):1747-63. PubMed ID: 15975943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelin antigen load influences antigen presentation and severity of central nervous system autoimmunity.
    Jaini R; Popescu DC; Flask CA; Macklin WB; Tuohy VK
    J Neuroimmunol; 2013 Jun; 259(1-2):37-46. PubMed ID: 23601904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.
    Sonobe Y; Jin S; Wang J; Kawanokuchi J; Takeuchi H; Mizuno T; Suzumura A
    Tohoku J Exp Med; 2007 Dec; 213(4):329-39. PubMed ID: 18075237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies.
    Stinissen P; Raus J; Zhang J
    Crit Rev Immunol; 1997; 17(1):33-75. PubMed ID: 9034723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune regulatory CNS-reactive CD8+T cells in experimental autoimmune encephalomyelitis.
    York NR; Mendoza JP; Ortega SB; Benagh A; Tyler AF; Firan M; Karandikar NJ
    J Autoimmun; 2010 Aug; 35(1):33-44. PubMed ID: 20172692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8+ T cells in inflammatory demyelinating disease.
    Weiss HA; Millward JM; Owens T
    J Neuroimmunol; 2007 Nov; 191(1-2):79-85. PubMed ID: 17920696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune regulation of multiple sclerosis by CD8+ T cells.
    Sinha S; Itani FR; Karandikar NJ
    Immunol Res; 2014 Aug; 59(1-3):254-65. PubMed ID: 24845461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.